AR013749A1 - Tratamiento de retinopatia diabetica - Google Patents
Tratamiento de retinopatia diabeticaInfo
- Publication number
- AR013749A1 AR013749A1 ARP980105654A ARP980105654A AR013749A1 AR 013749 A1 AR013749 A1 AR 013749A1 AR P980105654 A ARP980105654 A AR P980105654A AR P980105654 A ARP980105654 A AR P980105654A AR 013749 A1 AR013749 A1 AR 013749A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- diabetic retinopathy
- elliprodil
- glutamate
- antagonist compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe el uso de composiciones de antagonistas de excitotoxicidad inducida por glutamato para el tratamiento de retinopatía diabética tal comoeleliprodil.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6569497P | 1997-11-14 | 1997-11-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013749A1 true AR013749A1 (es) | 2001-01-10 |
Family
ID=22064483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105654A AR013749A1 (es) | 1997-11-14 | 1998-11-09 | Tratamiento de retinopatia diabetica |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR013749A1 (es) |
AU (1) | AU9797598A (es) |
WO (1) | WO1999025350A1 (es) |
ZA (1) | ZA989514B (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050009884A1 (en) * | 1997-06-30 | 2005-01-13 | Dreyer Evan B. | Calcium blockers to treat proliferative retinal diseases |
JP2008507588A (ja) * | 2004-07-26 | 2008-03-13 | アラーガン、インコーポレイテッド | 眼の病態を処置する方法 |
US20070203144A1 (en) * | 2006-01-17 | 2007-08-30 | Allergan, Inc. | Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals |
WO2011112243A2 (en) * | 2010-03-08 | 2011-09-15 | The University Of Tennessee Research Foundation | Beta -adrenergic receptor agonists and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4807790A (en) * | 1988-12-05 | 1990-06-26 | Houston Biotechnology Incorporated | Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction |
US5521215A (en) * | 1989-11-07 | 1996-05-28 | Ramot University Authority For Applied Research And Industrial Development Ltd. | NMDA-blocking pharmaceuticals |
US5856329A (en) * | 1995-06-28 | 1999-01-05 | Allergan | Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
FR2738568B1 (fr) * | 1995-09-08 | 1997-10-17 | Synthelabo | Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique |
CA2251857A1 (en) * | 1996-04-17 | 1997-10-23 | Tohru Tatsuno | Remedy for retinal neuropathy |
-
1998
- 1998-10-09 WO PCT/US1998/021423 patent/WO1999025350A1/en active Application Filing
- 1998-10-09 AU AU97975/98A patent/AU9797598A/en not_active Abandoned
- 1998-10-19 ZA ZA989514A patent/ZA989514B/xx unknown
- 1998-11-09 AR ARP980105654A patent/AR013749A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU9797598A (en) | 1999-06-07 |
ZA989514B (en) | 1999-06-15 |
WO1999025350A1 (en) | 1999-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT199900217A (es) | Compuestos empleados en el tratamiento de padecimientos inflamatorios. | |
AR011611A1 (es) | Composiciones en gel postespumante | |
ES2194314T3 (es) | Derivados de benzopirano sustituidos para el tratamiento de inflamaciones. | |
BRPI0417684A (pt) | composto, composição farmacêutica, e, uso de um composto | |
PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
ES2157027T3 (es) | Oxazolidinonas sustituidas y su uso como farmacos antibacterianos. | |
ES2189256T3 (es) | Composiciones de mezclas de ester de cianoacrilato. | |
ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
CR6592A (es) | Compuestos para el tratamiento de la isquemia | |
DK0717041T3 (da) | Krystallinske paclitaxel-hydrater | |
ES2176795T3 (es) | Composiciones a base de esfingomielanasa y su utilizacion. | |
ES2190246T3 (es) | Nuevos compuestos de tiazolopirimidina. | |
ES2202855T3 (es) | Uso de antagonistas 5ht3 para promover el lavado intestinal. | |
MX17808A (es) | Nuevos derivados de artemisinina,procedimiento para su preparacion y su uso como agentes antiprosoos | |
BR9909486A (pt) | Compostos calcilìticos | |
ES2163867T3 (es) | Composicion para el control del polvo. | |
AR015945A1 (es) | Composiciones de spray para el cabello autofobicas | |
UY27203A1 (es) | Bencimidazoles útiles en el tratamiento de la disfunción sexual | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
SE9801494D0 (sv) | Novel use | |
CO4230021A1 (es) | Glicosidos esteroideos, procedimientos de uso de los mismos como agentes hipocolesterolemicos y agentes antiateroscle- roticos en mamiferos. | |
ES2177811T3 (es) | Uso de nitroflavonoides para el tratamiento de la ansiedad. | |
AR013749A1 (es) | Tratamiento de retinopatia diabetica | |
DK1250337T3 (da) | Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter |